)
AnaptysBio (ANAB) investor relations material
AnaptysBio Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for August 11, 2026, with proxy materials available online and by request.
Shareholders of record as of June 22, 2026, are eligible to vote on key proposals.
Voting matters and shareholder proposals
Election of two Class III directors for three-year terms: Hollings Renton and John P. Schmid.
Ratification of KPMG LLP as independent auditor for fiscal year ending June 30, 2027.
Advisory vote on executive compensation (say-on-pay).
Approval of an amendment to the 2017 Equity Incentive Plan.
Board of directors and corporate governance
Board recommends voting in favor of all four proposals presented at the annual meeting.
- Rosnilimab showed record efficacy and strong safety in phase II-B/2b RA trial; more data Q2 2025.ANAB
Study Update8 Jul 2026 - Shareholders will vote on directors, auditor ratification, executive pay, and equity plan changes.ANAB
Proxy filing29 Jun 2026 - Spin-off completed; Jemperli royalties up 44%, net loss $52.9M, $100M buyback plan.ANAB
Q1 202612 May 2026 - Company to split, with strong Jemperli royalties and ANB033 clinical data expected in Q4.ANAB
Leerink Global Healthcare Conference 202611 Mar 2026 - Separation into biopharma and royalty entities unlocks value, with strong clinical and royalty catalysts.ANAB
Corporate presentation10 Mar 2026 - Biopharma spin-off advances antibody pipeline as royalty business leverages Jemperli growth.ANAB
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Business split, strong JEMPERLI royalties, and key clinical milestones set for 2024.ANAB
TD Cowen 46th Annual Health Care Conference4 Mar 2026 - Q2 2026 spin-off, strong Jemperli royalties, and improved Q4 net income highlight results.ANAB
Q4 20253 Mar 2026 - Separation in Q2 will unlock value from Jemperli royalties and advance a promising clinical pipeline.ANAB
Piper Sandler Virtual Novel Targets in Immunology Symposium12 Feb 2026
Next AnaptysBio earnings date
Next AnaptysBio earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)